BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36749091)

  • 21. Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis.
    Liu J; Li H; Zheng B; Sun L; Yuan Y; Xing C
    Dig Dis Sci; 2019 Jul; 64(7):1868-1877. PubMed ID: 30734239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated Analysis of lncRNA-Associated ceRNA Network Identifies Two lncRNA Signatures as a Prognostic Biomarker in Gastric Cancer.
    Zhang S; Li S; Guo JL; Li N; Zhang CN; Liu J
    Dis Markers; 2021; 2021():8886897. PubMed ID: 34603561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
    Tang Z; Wei G; Zhang L; Xu Z
    Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and Analysis of lncRNA-miRNA-mRNA ceRNA Network Identify an Eight-Gene Signature as a Potential Prognostic Factor in Kidney Renal Papillary Cell Carcinoma (KIRP).
    Yang L; Ma TJ; Zhang YB; Wang H; An RH
    Altern Ther Health Med; 2022 Sep; 28(6):42-51. PubMed ID: 35648698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
    Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TCGA dataset‑based construction and integrated analysis of aberrantly expressed long non‑coding RNA mediated competing endogenous RNA network in gastric cancer.
    He W; Zhang D; Li X; Wu J; Yang X; Wang Q; Lu W; Jiang J; Wu C
    Oncol Rep; 2018 Dec; 40(6):3511-3522. PubMed ID: 30272352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor.
    Zheng H; Li BH; Liu C; Jia L; Liu FT
    Biomed Res Int; 2020; 2020():4951692. PubMed ID: 32149111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
    Zha Z; Zhang P; Li D; Liu G; Lu L
    Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
    Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
    J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of a competing endogenous RNA co-expression network as a prognostic marker in glioblastoma.
    Peng Q; Li R; Li Y; Xu X; Ni W; Lin H; Ning L
    J Cell Mol Med; 2020 Nov; 24(22):13346-13355. PubMed ID: 33047898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
    Jia X; Shi Y; Zhu Y; Meng W; He L; Jia Y; Tong Z
    J Comput Biol; 2020 Jul; 27(7):1055-1066. PubMed ID: 31647320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
    Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
    J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer.
    Tuersong T; Li L; Abulaiti Z; Feng S
    Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma.
    Chen F; Li Z; Deng C; Yan H
    J Transl Med; 2019 Aug; 17(1):299. PubMed ID: 31470869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.